Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 3
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07489924Phase 4Active Not Recruiting

Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis.

Role: collaborator

NCT02831699Completed

The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico

Role: collaborator

NCT03168282Terminated

Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico

Role: collaborator

NCT01717118Phase 4Completed

Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico

Role: collaborator

NCT02510027Unknown

Triage Strategies in Cervical Cancer Prevention

Role: collaborator

NCT02382900Phase 3Unknown

Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City

Role: collaborator

NCT01418287Completed

Characterization of Influenza-like Illness in Mexico

Role: collaborator

NCT02104973Not ApplicableUnknown

Obesity Prevention in Schoolchildren

Role: collaborator

NCT01966874Completed

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation

Role: collaborator

NCT01099293Completed

Cerebrovascular Reactivity in Hepatic Encephalopathy

Role: collaborator

All 10 trials loaded